Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GWP42006 PK and Safety in Focal Seizures
NCT02369471Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of cannabidivarin in focal seizures (6 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Pharmacokinetic parameters of GWP42006 and metabolites at Day 18. Started Mar 2015; status: completed.
02
Drugs
cannabidivarin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT02369471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369471.